The full-service Contract Research Organization (CRO) with operations in Australia, New Zealand, Asia, North America, and Europe, delivering high quality clinical research services to biotech companies for more than three decades.

Avance Clinical specializes in world-class operations, providing biotechs with strategic guidance from their pre-clinical development to Phase I early phase with our experienced ClinicReady team through to Phase II to III late-phase studies, supported by our proven GlobalReady team.

Our focus and approach is one that is dedicated to biotechs who require a CRO partner that delivers fast, agile, and adaptive operations. We understand how critical it is to biotechs that we offer high quality, solution-oriented and innovative project delivery teams to work on their projects. In parallel, we offer a cost-effective model that ensures rapid delivery of results with robust, globally accepted data.

With a proven track record and experience spanning across more than 120+ indications, Avance Clinical consistently delivers high-quality data that is accepted by global regulators, including but not limited to the TGA, FDA, MHRA, EMA, MFDS, PDMA.

Avance Clinical distinguishes itself by its commitment to personalized service rather than a one-size-fits-all approach.

Early Phase Success

From comprehensive pre-clinical consultancy services through to phase I trials, Avance Clinical offers fast, agile and adaptive clinical research solutions for biotechs in Australia and New Zealand, in the early phases of their drug development.

The ClinicReady team, our inhouse scientific and regulatory affairs experts, embed themselves early into our client’s drug development team and lay the vital clinical foundations that ensure seamless and successful transition into phase I and beyond.

Late Phase Success

Our Late phase operations deliver multi-regional, Phase II and III clinical excellence across key therapeutic areas including but not limited to, oncology, CNS, rare diseases and infectious diseases. Our global teams apply decades of drug development experience, and leverage the latest technology, including AI and gold standard systems and processes, across all functional areas to deliver an exceptional CRO experience for biotechs.